全文获取类型
收费全文 | 179687篇 |
免费 | 34548篇 |
国内免费 | 2465篇 |
专业分类
耳鼻咽喉 | 5415篇 |
儿科学 | 6255篇 |
妇产科学 | 2975篇 |
基础医学 | 7583篇 |
口腔科学 | 1923篇 |
临床医学 | 29447篇 |
内科学 | 54372篇 |
皮肤病学 | 8087篇 |
神经病学 | 17562篇 |
特种医学 | 7246篇 |
外国民族医学 | 3篇 |
外科学 | 44983篇 |
综合类 | 613篇 |
现状与发展 | 72篇 |
一般理论 | 30篇 |
预防医学 | 9611篇 |
眼科学 | 3903篇 |
药学 | 2704篇 |
1篇 | |
中国医学 | 62篇 |
肿瘤学 | 13853篇 |
出版年
2024年 | 516篇 |
2023年 | 4827篇 |
2022年 | 1244篇 |
2021年 | 3409篇 |
2020年 | 6203篇 |
2019年 | 2518篇 |
2018年 | 7807篇 |
2017年 | 7615篇 |
2016年 | 8739篇 |
2015年 | 8808篇 |
2014年 | 16094篇 |
2013年 | 16572篇 |
2012年 | 6988篇 |
2011年 | 7133篇 |
2010年 | 11328篇 |
2009年 | 15200篇 |
2008年 | 7416篇 |
2007年 | 5810篇 |
2006年 | 8262篇 |
2005年 | 5633篇 |
2004年 | 4755篇 |
2003年 | 3726篇 |
2002年 | 3761篇 |
2001年 | 4398篇 |
2000年 | 3567篇 |
1999年 | 3788篇 |
1998年 | 4053篇 |
1997年 | 3843篇 |
1996年 | 3676篇 |
1995年 | 3516篇 |
1994年 | 2235篇 |
1993年 | 1836篇 |
1992年 | 1872篇 |
1991年 | 1893篇 |
1990年 | 1497篇 |
1989年 | 1572篇 |
1988年 | 1373篇 |
1987年 | 1211篇 |
1986年 | 1221篇 |
1985年 | 1076篇 |
1984年 | 849篇 |
1983年 | 794篇 |
1982年 | 789篇 |
1981年 | 684篇 |
1980年 | 572篇 |
1979年 | 558篇 |
1978年 | 544篇 |
1977年 | 583篇 |
1975年 | 442篇 |
1972年 | 436篇 |
排序方式: 共有10000条查询结果,搜索用时 672 毫秒
41.
42.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
43.
44.
45.
46.
47.
48.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
49.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
50.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献